Common Contracts
4 similar null contracts by Genta Inc De/, Hythiam Inc, Idm Pharma, Inc., Titan Pharmaceuticals Inc
CONFIDENTIAL Richard J. Moran Chief Financial Officer Genta Incorporated 200 Connell Drive Berkeley Heights, NJ 07922 Dear Mr. Moran:Genta Inc De/ • February 11th, 2008 • Biological products, (no disgnostic substances)
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“R&R” or the “Placement Agent”) and Genta Incorporated (the “Company”), that R&R shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities (the “Registered Securities”) of the Company, including shares (the “Shares”) of the Company’s common stock (the “Common Stock”) (sometimes referred to as, the “Securities”). Rodman shall be authorized to utilize sub-placement agents and/or selected dealers in its discretion, provided that the use of any sub-placement agent and/or selected dealer by Rodman shall not increase any fees (including cash or Warrants) or expenses payable by the Company under this Agreement. The terms of such Placement and Offering and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purcha
CONFIDENTIAL Hythiam, Inc. 11150 Santa Monica Boulevard Suite 1500 Los Angeles CA 90025 Attn: Terren S. Peizer, Chairman & CEO Dear Terren:Hythiam Inc • November 7th, 2007 • Services-misc health & allied services, nec • New York
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“R&R” or the “Placement Agent”) and Hythiam, Inc. (the “Company”), that R&R shall serve as a placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities (the “Securities”) of the Company, including shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and warrants to purchase shares of Common Stock. The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that R&R would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection w
CONFIDENTIAL Timothy P. Walbert IDM Pharma, Inc. 9 Parker, Suite 100 Irvine, CA 92618 Dear Mr. Walbert:Idm Pharma, Inc. • June 21st, 2007 • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“R&R” or the “Placement Agent”) and IDM Pharma, Inc. (the “Company”), that R&R shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities (the “Securities”) of the Company, including shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and warrants to purchase shares of Common Stock (“Warrants”). The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that R&R would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the
DRAFT CONFIDENTIAL Louis R. Bucalo, M.D. Chairman, President & Chief Executive Officer Titan Pharmaceuticals, Inc.Titan Pharmaceuticals Inc • April 26th, 2007 • Biological products, (no disgnostic substances) • New York
